JP2002516282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002516282A5 JP2002516282A5 JP2000550487A JP2000550487A JP2002516282A5 JP 2002516282 A5 JP2002516282 A5 JP 2002516282A5 JP 2000550487 A JP2000550487 A JP 2000550487A JP 2000550487 A JP2000550487 A JP 2000550487A JP 2002516282 A5 JP2002516282 A5 JP 2002516282A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- component
- pharmaceutical composition
- effective amount
- severe depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8644498P | 1998-05-22 | 1998-05-22 | |
| US60/086,444 | 1998-05-22 | ||
| PCT/US1999/011276 WO1999061027A1 (en) | 1998-05-22 | 1999-05-21 | Combination therapy for treatment of refractory depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002516282A JP2002516282A (ja) | 2002-06-04 |
| JP2002516282A5 true JP2002516282A5 (https=) | 2006-07-06 |
Family
ID=22198612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000550487A Pending JP2002516282A (ja) | 1998-05-22 | 1999-05-21 | 難治性鬱病の処置のための組合せ治療 |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0958824A3 (https=) |
| JP (1) | JP2002516282A (https=) |
| KR (1) | KR20010043730A (https=) |
| CN (1) | CN1154496C (https=) |
| AU (1) | AU761510B2 (https=) |
| BR (1) | BR9911049A (https=) |
| CA (1) | CA2332814C (https=) |
| CZ (1) | CZ20004279A3 (https=) |
| EA (1) | EA004539B1 (https=) |
| HK (1) | HK1040055B (https=) |
| HR (1) | HRP20000797A2 (https=) |
| HU (1) | HUP0101901A3 (https=) |
| ID (1) | ID26861A (https=) |
| IL (1) | IL139592A (https=) |
| MY (1) | MY127938A (https=) |
| NO (1) | NO20005885L (https=) |
| NZ (1) | NZ507980A (https=) |
| PL (1) | PL344331A1 (https=) |
| SK (1) | SK17512000A3 (https=) |
| TR (1) | TR200003443T2 (https=) |
| TW (1) | TWI226829B (https=) |
| UA (1) | UA78181C2 (https=) |
| WO (1) | WO1999061027A1 (https=) |
| ZA (1) | ZA200006815B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174882B1 (en) * | 1998-11-23 | 2001-01-16 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| SI1237553T1 (sl) * | 1999-12-06 | 2006-06-30 | Lundbeck & Co As H | Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| JP2004517112A (ja) * | 2001-01-02 | 2004-06-10 | ファルマシア・アンド・アップジョン・カンパニー | 新規薬物コンビネーション |
| AU2003268026A1 (en) | 2002-07-30 | 2004-02-16 | Peter Migaly | Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions |
| GB0229583D0 (en) * | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
| CN1989968B (zh) | 2002-12-27 | 2011-05-11 | 大塚制药株式会社 | 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂 |
| AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
| FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
| AU2004269858A1 (en) * | 2003-09-04 | 2005-03-17 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and Loxapine |
| SI1668014T1 (sl) | 2003-09-17 | 2009-06-30 | Janssen Pharmaceutica Nv | Kondenzirane heterociklične spojine kot modulatorji serotoninskih receptorjev |
| WO2005053703A1 (en) | 2003-12-02 | 2005-06-16 | Leslie James Sheldon | Combination therapy for dementia, depression and apathy |
| EP1696896A2 (en) * | 2003-12-15 | 2006-09-06 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| US7598255B2 (en) * | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| EP1928437A2 (en) * | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2044043B2 (en) | 2006-06-16 | 2021-03-03 | H. Lundbeck A/S | 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine hydrobromide as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| PL2120878T3 (pl) * | 2007-02-09 | 2015-01-30 | Alphapharm Pty Ltd | Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych |
| TWI432194B (zh) * | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途 |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| CN105769875A (zh) * | 2014-12-22 | 2016-07-20 | 扬子江药业集团上海海尼药业有限公司 | 复方奥氮平盐酸氟西汀胶囊的制备方法 |
| CN108938645A (zh) * | 2018-08-24 | 2018-12-07 | 山西医科大学第医院 | 一种抗精神病药物组合物 |
| CN111084778B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种奥氮平盐酸氟西汀胶囊及其制备方法 |
| CN114569566A (zh) * | 2020-12-02 | 2022-06-03 | 四川科瑞德制药股份有限公司 | 一种盐酸米那普仑制剂的制备方法 |
| ES3054324A1 (es) * | 2024-07-12 | 2026-02-02 | Univ Malaga | Galanina (1-15) y Fluoxetina en el tratamiento de la depresión resistente al tratamiento |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8072691A (en) * | 1990-06-28 | 1992-01-23 | Beecham Group Plc | Pharmaceutical preparations |
| FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| WO1997033577A1 (en) * | 1996-03-11 | 1997-09-18 | Eli Lilly And Company | Method for treating bipolar disorder |
| WO1997035586A1 (en) * | 1996-03-25 | 1997-10-02 | Eli Lilly And Company | Method for treating pain |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
-
1999
- 1999-05-21 BR BR9911049-0A patent/BR9911049A/pt not_active Application Discontinuation
- 1999-05-21 UA UA2000116623A patent/UA78181C2/uk unknown
- 1999-05-21 EP EP99303969A patent/EP0958824A3/en not_active Withdrawn
- 1999-05-21 TR TR2000/03443T patent/TR200003443T2/xx unknown
- 1999-05-21 IL IL13959299A patent/IL139592A/xx not_active IP Right Cessation
- 1999-05-21 CA CA002332814A patent/CA2332814C/en not_active Expired - Fee Related
- 1999-05-21 NZ NZ507980A patent/NZ507980A/en unknown
- 1999-05-21 SK SK1751-2000A patent/SK17512000A3/sk unknown
- 1999-05-21 EA EA200001218A patent/EA004539B1/ru not_active IP Right Cessation
- 1999-05-21 HU HU0101901A patent/HUP0101901A3/hu unknown
- 1999-05-21 KR KR1020007013059A patent/KR20010043730A/ko not_active Abandoned
- 1999-05-21 JP JP2000550487A patent/JP2002516282A/ja active Pending
- 1999-05-21 CN CNB998090719A patent/CN1154496C/zh not_active Expired - Fee Related
- 1999-05-21 TW TW088108382A patent/TWI226829B/zh not_active IP Right Cessation
- 1999-05-21 CZ CZ20004279A patent/CZ20004279A3/cs unknown
- 1999-05-21 HR HR20000797A patent/HRP20000797A2/hr not_active Application Discontinuation
- 1999-05-21 MY MYPI99002017A patent/MY127938A/en unknown
- 1999-05-21 HK HK02101563.3A patent/HK1040055B/zh not_active IP Right Cessation
- 1999-05-21 AU AU40086/99A patent/AU761510B2/en not_active Ceased
- 1999-05-21 PL PL99344331A patent/PL344331A1/xx not_active Application Discontinuation
- 1999-05-21 ID IDW20002339A patent/ID26861A/id unknown
- 1999-05-21 WO PCT/US1999/011276 patent/WO1999061027A1/en not_active Ceased
-
2000
- 2000-11-21 NO NO20005885A patent/NO20005885L/no unknown
- 2000-11-21 ZA ZA200006815A patent/ZA200006815B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002516282A5 (https=) | ||
| Vulink et al. | Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. | |
| US4777173A (en) | Method for treatment of alcohol abuse | |
| Biri et al. | Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study | |
| Farlow | Pharmacokinetic profiles of current therapiesfor Alzheimer's disease: implications for switching to galantamine | |
| JP2007512371A5 (https=) | ||
| KR980000447A (ko) | 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물 | |
| WO2002053140A3 (en) | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents | |
| WO2001062236A3 (en) | New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent | |
| JP2013544850A5 (https=) | ||
| HUP0400054A2 (hu) | Enantiomerszerűen tiszta escitalopram alkalmazása | |
| BRPI0414347A (pt) | associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade | |
| Walsh et al. | The pharmacologic treatment of eating disorders | |
| JP2003504332A5 (https=) | ||
| Lauerma | Successful treatment of citalopram‐induced anorgasmia by cyproheptadine | |
| DeBattista et al. | Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs | |
| BRPI0713733A2 (pt) | métodos para diminuir os sintomas de depressão e para tratar uma ou mais condições psicológicas, composição farmacêutica e kit | |
| Khawaja et al. | Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| WO2002039879A3 (en) | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine | |
| JP2003522112A5 (https=) | ||
| JP2007505156A5 (https=) | ||
| JP2002530341A5 (https=) | ||
| Piediferro et al. | Premature ejaculation. 3. Therapy | |
| JP2008503445A5 (https=) |